Terms: = Prostate cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721
713 results:
1. [Explore the mechanism of astragaloside IV-PESV on proliferation, migration, and autophagy of prostate cancer cells based on the PI3K/AKT signaling pathway].
You XJ; Wen Z; Zheng QX; Li QX; Fu W; Li HS; Wang B
Zhonghua Nan Ke Xue; 2023 Dec; 29(12):963-972. PubMed ID: 38639947
[TBL] [Abstract] [Full Text] [Related]
2. Dishevelled Segment Polarity Protein 3 (DVL3) Induced by Bacterial LPS Promotes the Proliferation and Migration of prostate cancer Cells through the TLR4 Pathway.
Zhang Y; Lin N; Liu X; Yao T
Arch Esp Urol; 2024 Mar; 77(2):193-201. PubMed ID: 38583012
[TBL] [Abstract] [Full Text] [Related]
3. Long Non-Coding RNA NUTM2A-AS1/miR-376a-3p/PRMT5 Axis Promotes prostate cancer Progression.
Han H; Li Z; Bi L; Zhang J
Arch Esp Urol; 2024 Mar; 77(2):173-182. PubMed ID: 38583010
[TBL] [Abstract] [Full Text] [Related]
4. Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder.
Zhang C; Xu X; Wang T; Lu Y; Lu Z; Wang T; Pan Z
Sci Rep; 2024 Apr; 14(1):7941. PubMed ID: 38575639
[TBL] [Abstract] [Full Text] [Related]
5. A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment.
He Y; Yu Q; Ma X; Lv D; Wang H; Qiu W; Chen XF; Jiao Y; Liu Y
J Ethnopharmacol; 2024 Jun; 328():118075. PubMed ID: 38513779
[TBL] [Abstract] [Full Text] [Related]
6. PEI, a new transfection method, augments the inhibitory effect of RBM5 on prostate cancer.
Zhou X; Cao Y; Li R; Di X; Wang Y; Wang K
Biochem Biophys Res Commun; 2024 Apr; 704():149703. PubMed ID: 38402723
[TBL] [Abstract] [Full Text] [Related]
7. New Derivatives of 1-(3-Methyl-1-Benzofuran-2-yl)Ethan-1-one: Synthesis and Preliminary Studies of Biological Activity.
Napiórkowska M; Kumaravel P; Amboo Mahentheran M; Kiernozek-Kalińska E; Grosicka-Maciąg E
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396676
[TBL] [Abstract] [Full Text] [Related]
8. Curcumin Enhances the Anti-cancer Efficacy of CDK4/6 Inhibitors in prostate cancer.
Zhao H; Ding R; Han J
Arch Esp Urol; 2024 Jan; 77(1):57-66. PubMed ID: 38374014
[TBL] [Abstract] [Full Text] [Related]
9. CircTHSD4 promotes the malignancy and docetaxel (DTX) resistance in prostate cancer by regulating miR-203/HMGA2 axis.
Xie J; Lu L; Zhang J; Li Q; Chen W
Oncol Res; 2024; 32(3):529-544. PubMed ID: 38361751
[TBL] [Abstract] [Full Text] [Related]
10.
Zhao X; Zhao Z; Xie H; Gao W; Ye C
Discov Med; 2024 Jan; 36(180):61-70. PubMed ID: 38273746
[TBL] [Abstract] [Full Text] [Related]
11. High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor.
Wang F; Zhang G; Xu T; Ma J; Wang J; Liu S; Tang Y; Jin S; Li J; Xing N
J Exp Clin Cancer Res; 2024 Jan; 43(1):24. PubMed ID: 38245792
[TBL] [Abstract] [Full Text] [Related]
12. Serine/threonine kinase 36 induced epithelial-mesenchymal transition promotes docetaxel resistance in prostate cancer.
He T; Li NX; Pan ZJ; Zou ZH; Chen JC; Yu SZ; Lv F; Xie QC; Zou J
Sci Rep; 2024 Jan; 14(1):729. PubMed ID: 38184689
[TBL] [Abstract] [Full Text] [Related]
13. ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression.
Xu H; Li YF; Yi XY; Zheng XN; Yang Y; Wang Y; Liao DZ; Zhang JP; Tan P; Xiong XY; Jin X; Gong LN; Qiu S; Cao DH; Li H; Wei Q; Yang L; Ai JZ
Mil Med Res; 2023 Dec; 10(1):64. PubMed ID: 38082365
[TBL] [Abstract] [Full Text] [Related]
14. Chrysosplenol D can inhibit the growth of prostate cancer by inducing reactive oxygen species and autophagy.
Zhang H; You Z; Li Y; Gao C; Wang Y; Zhang X
Immun Inflamm Dis; 2023 Oct; 11(10):e1061. PubMed ID: 37904714
[TBL] [Abstract] [Full Text] [Related]
15. Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-STAT3 in prostate cancer.
Wang L; Lyu C; Stadlbauer B; Buchner A; Nößner E; Pohla H
Prostate; 2024 Feb; 84(2):131-147. PubMed ID: 37828768
[TBL] [Abstract] [Full Text] [Related]
16. [Effects of Xihuang Pills on proliferation and apoptosis of prostate cancer LNCaP cells based on AR/m TOR signaling pathway].
Dai XJ; Long Y; Zou B; Wu LT; Qiu JF; Wu YR; Deng Z; Wang YL; Zhou Q; Tian XF
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4147-4155. PubMed ID: 37802783
[TBL] [Abstract] [Full Text] [Related]
17. Polyphyllin I induces ferroptosis in castration-resistant prostate cancer cells through the ERK/DNMT1/ACSL4 axis.
Zou P; Chen Z; He Q; Zhuo Y
Prostate; 2024 Jan; 84(1):64-73. PubMed ID: 37750290
[TBL] [Abstract] [Full Text] [Related]
18. Bulk RNA-Seq Combined with Single-Cell Transcriptome Sequencing Reveals the Possible Mechanisms by Which HDGFL3 Involves in prostate cancer Growth and Metastasis.
Xiao C; Liang W
Arch Esp Urol; 2023 Aug; 76(6):425-438. PubMed ID: 37681334
[TBL] [Abstract] [Full Text] [Related]
19. Berbamine Inhibits the Biological Activities of prostate cancer Cells by Modulating the ROS/NF-κB Axis.
Zhao W; Jiang Y; Jia X; Wang X; Guo Y
Anticancer Agents Med Chem; 2023; 23(14):1626-1633. PubMed ID: 37638593
[TBL] [Abstract] [Full Text] [Related]
20. LINC01088/miR-22/CDC6 Axis Regulates prostate cancer Progression by Activating the PI3K/AKT Pathway.
Li J; Huang X; Chen H; Gu C; Ni B; Zhou J
Mediators Inflamm; 2023; 2023():9207148. PubMed ID: 37501932
[TBL] [Abstract] [Full Text] [Related]
[Next]
